Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in Portugal

Detalhes bibliográficos
Autor(a) principal: Guiomar, R
Data de Publicação: 2017
Outros Autores: Pereira da Silva, S, Conde, P, Cristóvão, P, Maia, AC, Pechirra, P, Rodrigues, AP, Nunes, B, Milho, L, Coelho, AP, Fernandes, A, Caseiro, P, Rodrigues, F, Correia, L, Pereira-Vaz, J, Almeida, S, Branquinho, P, Côrte-Real, R, Viseu, R, Peres, MJ, Sanches, R, Dantas, F, Freitas, L, Andrade, G, Maurílio, M, Caldeira, F, Cabral Veloso, R, Mota-Vieira, L, Soares, M, Couto, AR, Bruges-Armas, J, Mouro Pinto, R, Sobrinho Simões, J, Costa, MR, Guimarães, JT, Martins, L, Cunha, M
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/3358
Resumo: INTRODUCTION: Immune profile for influenza viruses is highly changeable over time. Serological studies can assess the prevalence of influenza, estimate the risk of infection, highlight asymptomatic infection rate and can also provide data on vaccine coverage. The aims of the study were to evaluate pre-existing cross-protection against influenza A(H3) drift viruses and to assess influenza immunity in the Portuguese population. MATERIALS AND METHODS: We developed a cross-sectional study based on a convenience sample of 626 sera collected during June 2014, covering all age groups, both gender and all administrative health regions of Portugal. Sera antibody titers for seasonal and new A(H3) drift influenza virus were evaluated by hemagglutination inhibition assay (HI). Seroprevalence to each seasonal influenza vaccine strain virus and to the new A(H3) drift circulating strain was estimated by age group, gender and region and compared with seasonal influenza-like illness (ILI) incidence rates before and after the study period. RESULTS: Our findings suggest that seroprevalences of influenza A(H3) (39.9%; 95% CI: 36.2-43.8) and A(H1)pdm09 (29.7%; 95% CI: 26.3-33.4) antibodies were higher than for influenza B, in line with high ILI incidence rates for A(H3) followed by A(H1)pdm09, during 2013/2014 season. Low pre-existing cross-protection against new A(H3) drift viruses were observed in A(H3) seropositive individuals (46%). Both against influenza A(H1)pdm09 and A(H3) seroprotection was highest in younger than 14-years old. Protective antibodies against influenza B were highest in those older than 65years old, especially for B/Yamagata lineage, 33.3% (95% CI: 25.7-41.9). Women showed a high seroprevalence to influenza, although without statistical significance, when compared to men. A significant decreasing trend in seroprotection from north to south regions of Portugal mainland was observed. CONCLUSIONS: Our results emphasize that low seroprotection increases the risk of influenza infection in the following winter season. Seroepidemiological studies can inform policy makers on the need for vaccination and additional preventive measures.
id RCAP_9aba2a449f52aa549ce9c89187035b41
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/3358
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in PortugalAdolescentAdultAgedAged, 80 and overAntibodies, ViralChildChild, PreschoolCross-Sectional StudiesFemaleHemagglutination Inhibition TestsHumansIncidenceInfantInfant, NewbornInfluenza A virusInfluenza, HumanMaleMiddle AgedPortugalSeroepidemiologic StudiesYoung AdultCross ProtectionCHLC PAT CLININTRODUCTION: Immune profile for influenza viruses is highly changeable over time. Serological studies can assess the prevalence of influenza, estimate the risk of infection, highlight asymptomatic infection rate and can also provide data on vaccine coverage. The aims of the study were to evaluate pre-existing cross-protection against influenza A(H3) drift viruses and to assess influenza immunity in the Portuguese population. MATERIALS AND METHODS: We developed a cross-sectional study based on a convenience sample of 626 sera collected during June 2014, covering all age groups, both gender and all administrative health regions of Portugal. Sera antibody titers for seasonal and new A(H3) drift influenza virus were evaluated by hemagglutination inhibition assay (HI). Seroprevalence to each seasonal influenza vaccine strain virus and to the new A(H3) drift circulating strain was estimated by age group, gender and region and compared with seasonal influenza-like illness (ILI) incidence rates before and after the study period. RESULTS: Our findings suggest that seroprevalences of influenza A(H3) (39.9%; 95% CI: 36.2-43.8) and A(H1)pdm09 (29.7%; 95% CI: 26.3-33.4) antibodies were higher than for influenza B, in line with high ILI incidence rates for A(H3) followed by A(H1)pdm09, during 2013/2014 season. Low pre-existing cross-protection against new A(H3) drift viruses were observed in A(H3) seropositive individuals (46%). Both against influenza A(H1)pdm09 and A(H3) seroprotection was highest in younger than 14-years old. Protective antibodies against influenza B were highest in those older than 65years old, especially for B/Yamagata lineage, 33.3% (95% CI: 25.7-41.9). Women showed a high seroprevalence to influenza, although without statistical significance, when compared to men. A significant decreasing trend in seroprotection from north to south regions of Portugal mainland was observed. CONCLUSIONS: Our results emphasize that low seroprotection increases the risk of influenza infection in the following winter season. Seroepidemiological studies can inform policy makers on the need for vaccination and additional preventive measures.ElsevierRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEGuiomar, RPereira da Silva, SConde, PCristóvão, PMaia, ACPechirra, PRodrigues, APNunes, BMilho, LCoelho, APFernandes, ACaseiro, PRodrigues, FCorreia, LPereira-Vaz, JAlmeida, SBranquinho, PCôrte-Real, RViseu, RPeres, MJSanches, RDantas, FFreitas, LAndrade, GMaurílio, MCaldeira, FCabral Veloso, RMota-Vieira, LSoares, MCouto, ARBruges-Armas, JMouro Pinto, RSobrinho Simões, JCosta, MRGuimarães, JTMartins, LCunha, M2019-11-12T16:11:52Z20172017-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3358engVaccine. 2017 Apr 11;35(16):2092-2099.10.1016/j.vaccine.2017.02.019info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:42:34Zoai:repositorio.chlc.min-saude.pt:10400.17/3358Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:20:40.574697Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in Portugal
title Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in Portugal
spellingShingle Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in Portugal
Guiomar, R
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Viral
Child
Child, Preschool
Cross-Sectional Studies
Female
Hemagglutination Inhibition Tests
Humans
Incidence
Infant
Infant, Newborn
Influenza A virus
Influenza, Human
Male
Middle Aged
Portugal
Seroepidemiologic Studies
Young Adult
Cross Protection
CHLC PAT CLIN
title_short Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in Portugal
title_full Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in Portugal
title_fullStr Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in Portugal
title_full_unstemmed Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in Portugal
title_sort Cross-Protection to New Drifted Influenza A(H3) Viruses and Prevalence of Protective Antibodies to Seasonal Influenza, During 2014 in Portugal
author Guiomar, R
author_facet Guiomar, R
Pereira da Silva, S
Conde, P
Cristóvão, P
Maia, AC
Pechirra, P
Rodrigues, AP
Nunes, B
Milho, L
Coelho, AP
Fernandes, A
Caseiro, P
Rodrigues, F
Correia, L
Pereira-Vaz, J
Almeida, S
Branquinho, P
Côrte-Real, R
Viseu, R
Peres, MJ
Sanches, R
Dantas, F
Freitas, L
Andrade, G
Maurílio, M
Caldeira, F
Cabral Veloso, R
Mota-Vieira, L
Soares, M
Couto, AR
Bruges-Armas, J
Mouro Pinto, R
Sobrinho Simões, J
Costa, MR
Guimarães, JT
Martins, L
Cunha, M
author_role author
author2 Pereira da Silva, S
Conde, P
Cristóvão, P
Maia, AC
Pechirra, P
Rodrigues, AP
Nunes, B
Milho, L
Coelho, AP
Fernandes, A
Caseiro, P
Rodrigues, F
Correia, L
Pereira-Vaz, J
Almeida, S
Branquinho, P
Côrte-Real, R
Viseu, R
Peres, MJ
Sanches, R
Dantas, F
Freitas, L
Andrade, G
Maurílio, M
Caldeira, F
Cabral Veloso, R
Mota-Vieira, L
Soares, M
Couto, AR
Bruges-Armas, J
Mouro Pinto, R
Sobrinho Simões, J
Costa, MR
Guimarães, JT
Martins, L
Cunha, M
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Guiomar, R
Pereira da Silva, S
Conde, P
Cristóvão, P
Maia, AC
Pechirra, P
Rodrigues, AP
Nunes, B
Milho, L
Coelho, AP
Fernandes, A
Caseiro, P
Rodrigues, F
Correia, L
Pereira-Vaz, J
Almeida, S
Branquinho, P
Côrte-Real, R
Viseu, R
Peres, MJ
Sanches, R
Dantas, F
Freitas, L
Andrade, G
Maurílio, M
Caldeira, F
Cabral Veloso, R
Mota-Vieira, L
Soares, M
Couto, AR
Bruges-Armas, J
Mouro Pinto, R
Sobrinho Simões, J
Costa, MR
Guimarães, JT
Martins, L
Cunha, M
dc.subject.por.fl_str_mv Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Viral
Child
Child, Preschool
Cross-Sectional Studies
Female
Hemagglutination Inhibition Tests
Humans
Incidence
Infant
Infant, Newborn
Influenza A virus
Influenza, Human
Male
Middle Aged
Portugal
Seroepidemiologic Studies
Young Adult
Cross Protection
CHLC PAT CLIN
topic Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Viral
Child
Child, Preschool
Cross-Sectional Studies
Female
Hemagglutination Inhibition Tests
Humans
Incidence
Infant
Infant, Newborn
Influenza A virus
Influenza, Human
Male
Middle Aged
Portugal
Seroepidemiologic Studies
Young Adult
Cross Protection
CHLC PAT CLIN
description INTRODUCTION: Immune profile for influenza viruses is highly changeable over time. Serological studies can assess the prevalence of influenza, estimate the risk of infection, highlight asymptomatic infection rate and can also provide data on vaccine coverage. The aims of the study were to evaluate pre-existing cross-protection against influenza A(H3) drift viruses and to assess influenza immunity in the Portuguese population. MATERIALS AND METHODS: We developed a cross-sectional study based on a convenience sample of 626 sera collected during June 2014, covering all age groups, both gender and all administrative health regions of Portugal. Sera antibody titers for seasonal and new A(H3) drift influenza virus were evaluated by hemagglutination inhibition assay (HI). Seroprevalence to each seasonal influenza vaccine strain virus and to the new A(H3) drift circulating strain was estimated by age group, gender and region and compared with seasonal influenza-like illness (ILI) incidence rates before and after the study period. RESULTS: Our findings suggest that seroprevalences of influenza A(H3) (39.9%; 95% CI: 36.2-43.8) and A(H1)pdm09 (29.7%; 95% CI: 26.3-33.4) antibodies were higher than for influenza B, in line with high ILI incidence rates for A(H3) followed by A(H1)pdm09, during 2013/2014 season. Low pre-existing cross-protection against new A(H3) drift viruses were observed in A(H3) seropositive individuals (46%). Both against influenza A(H1)pdm09 and A(H3) seroprotection was highest in younger than 14-years old. Protective antibodies against influenza B were highest in those older than 65years old, especially for B/Yamagata lineage, 33.3% (95% CI: 25.7-41.9). Women showed a high seroprevalence to influenza, although without statistical significance, when compared to men. A significant decreasing trend in seroprotection from north to south regions of Portugal mainland was observed. CONCLUSIONS: Our results emphasize that low seroprotection increases the risk of influenza infection in the following winter season. Seroepidemiological studies can inform policy makers on the need for vaccination and additional preventive measures.
publishDate 2017
dc.date.none.fl_str_mv 2017
2017-01-01T00:00:00Z
2019-11-12T16:11:52Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/3358
url http://hdl.handle.net/10400.17/3358
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Vaccine. 2017 Apr 11;35(16):2092-2099.
10.1016/j.vaccine.2017.02.019
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131302694223872